Prostate cancer: ESMO Consensus Conference Guidelines 2012.

Détails

ID Serval
serval:BIB_3E5CFB01FA34
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Prostate cancer: ESMO Consensus Conference Guidelines 2012.
Périodique
Annals of oncology
Auteur⸱e⸱s
Horwich A., Hugosson J., de Reijke T., Wiegel T., Fizazi K., Kataja V.
Collaborateur⸱rice⸱s
Panel Members, European Society for Medical Oncology
Contributeur⸱rice⸱s
Parker C., Bellmunt J., Berthold D., Bill-Axelson A., Carlsson S., Daugaard G., De Meerleer G., de Reijke T., Dearnaley D., Fizazi K., Fonteyne V., Gillessen S., Heinrich D., Horwich A., Hugosson J., Kataja V., Kwiatkowski M., Nilsson S., Padhani A., Papandreou C., Parker C., Roobol M., Sella A., Valdagni R., Van der Kwast T., Verhagen P., Wiegel T.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Statut éditorial
Publié
Date de publication
05/2013
Peer-reviewed
Oui
Volume
24
Numéro
5
Pages
1141-1162
Langue
anglais
Notes
Publication types: Consensus Development Conference ; Journal Article ; Practice Guideline ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological aspects. Before the conference, the expert panel prepared clinically relevant questions about prostate cancer in four areas for discussion as follows: diagnosis and staging, management of early localized disease, management of advanced localized disease and systemic disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

Mots-clé
Antineoplastic Agents, Hormonal/therapeutic use, Digital Rectal Examination, Humans, Lymph Nodes, Male, Prostate-Specific Antigen/analysis, Prostatic Neoplasms/diagnosis, Prostatic Neoplasms/drug therapy, Prostatic Neoplasms/radiotherapy, Prostatic Neoplasms/surgery
Pubmed
Open Access
Oui
Création de la notice
30/11/2016 23:28
Dernière modification de la notice
20/08/2019 14:35
Données d'usage